Logo image of EXK

ENDEAVOUR SILVER CORP (EXK) Stock Fundamental Analysis

NYSE:EXK - CA29258Y1034 - Common Stock

5.89 USD
-0.05 (-0.84%)
Last: 8/28/2025, 8:06:34 PM
5.84 USD
-0.05 (-0.85%)
After Hours: 8/28/2025, 8:06:34 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to EXK. EXK was compared to 155 industry peers in the Metals & Mining industry. EXK has a bad profitability rating. Also its financial health evaluation is rather negative. EXK is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

EXK had negative earnings in the past year.
EXK had a positive operating cash flow in the past year.
EXK had positive earnings in 4 of the past 5 years.
In the past 5 years EXK always reported a positive cash flow from operatings.
EXK Yearly Net Income VS EBIT VS OCF VS FCFEXK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

EXK's Return On Assets of -6.99% is on the low side compared to the rest of the industry. EXK is outperformed by 66.45% of its industry peers.
EXK's Return On Equity of -13.16% is on the low side compared to the rest of the industry. EXK is outperformed by 63.23% of its industry peers.
With a Return On Invested Capital value of 0.28%, EXK perfoms like the industry average, outperforming 47.10% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for EXK is significantly below the industry average of 12.86%.
Industry RankSector Rank
ROA -6.99%
ROE -13.16%
ROIC 0.28%
ROA(3y)-0.51%
ROA(5y)0.76%
ROE(3y)-0.98%
ROE(5y)0.74%
ROIC(3y)2.76%
ROIC(5y)N/A
EXK Yearly ROA, ROE, ROICEXK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

EXK has a Operating Margin (1.11%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of EXK has declined.
Looking at the Gross Margin, with a value of 16.47%, EXK is in line with its industry, outperforming 52.90% of the companies in the same industry.
In the last couple of years the Gross Margin of EXK has declined.
Industry RankSector Rank
OM 1.11%
PM (TTM) N/A
GM 16.47%
OM growth 3Y-2.72%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5YN/A
EXK Yearly Profit, Operating, Gross MarginsEXK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

More info and screens

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EXK is destroying value.
EXK has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, EXK has more shares outstanding
Compared to 1 year ago, EXK has a worse debt to assets ratio.
EXK Yearly Shares OutstandingEXK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
EXK Yearly Total Debt VS Total AssetsEXK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 1.86 indicates that EXK is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of EXK (1.86) is worse than 65.81% of its industry peers.
EXK has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
EXK has a Debt to Equity ratio (0.23) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z 1.86
ROIC/WACC0.03
WACC9.36%
EXK Yearly LT Debt VS Equity VS FCFEXK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 0.93 indicates that EXK may have some problems paying its short term obligations.
EXK's Current ratio of 0.93 is on the low side compared to the rest of the industry. EXK is outperformed by 85.81% of its industry peers.
A Quick Ratio of 0.65 indicates that EXK may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.65, EXK is doing worse than 82.58% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.65
EXK Yearly Current Assets VS Current LiabilitesEXK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

6

3. Growth

3.1 Past

EXK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -600.00%.
The Revenue has grown by 11.64% in the past year. This is quite good.
The Revenue has been growing by 12.33% on average over the past years. This is quite good.
EPS 1Y (TTM)-600%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
Revenue 1Y (TTM)11.64%
Revenue growth 3Y9.6%
Revenue growth 5Y12.33%
Sales Q2Q%46.41%

3.2 Future

EXK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 55.42% yearly.
EXK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 33.18% yearly.
EPS Next Y141.03%
EPS Next 2Y193.95%
EPS Next 3Y97.31%
EPS Next 5Y55.42%
Revenue Next Year81.85%
Revenue Next 2Y74.22%
Revenue Next 3Y46.65%
Revenue Next 5Y33.18%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EXK Yearly Revenue VS EstimatesEXK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
EXK Yearly EPS VS EstimatesEXK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 -0.2 0.4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EXK. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 11.09 indicates a reasonable valuation of EXK.
76.13% of the companies in the same industry are more expensive than EXK, based on the Price/Forward Earnings ratio.
EXK's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.78.
Industry RankSector Rank
PE N/A
Fwd PE 11.09
EXK Price Earnings VS Forward Price EarningsEXK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as EXK.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 45.18
EXK Per share dataEXK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

EXK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as EXK's earnings are expected to grow with 97.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y193.95%
EPS Next 3Y97.31%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EXK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ENDEAVOUR SILVER CORP

NYSE:EXK (8/28/2025, 8:06:34 PM)

After market: 5.84 -0.05 (-0.85%)

5.89

-0.05 (-0.84%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)11-03 2025-11-03
Inst Owners42.36%
Inst Owner Change15.58%
Ins Owners0.15%
Ins Owner ChangeN/A
Market Cap1.71B
Analysts78.18
Price Target6.91 (17.32%)
Short Float %10.6%
Short Ratio2.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2921.78%
Min EPS beat(2)-5248.51%
Max EPS beat(2)-595.05%
EPS beat(4)1
Avg EPS beat(4)-1901.52%
Min EPS beat(4)-5248.51%
Max EPS beat(4)218.79%
EPS beat(8)2
Avg EPS beat(8)-1033.96%
EPS beat(12)2
Avg EPS beat(12)-718.86%
EPS beat(16)3
Avg EPS beat(16)-586.26%
Revenue beat(2)2
Avg Revenue beat(2)0.08%
Min Revenue beat(2)0.04%
Max Revenue beat(2)0.11%
Revenue beat(4)3
Avg Revenue beat(4)-2.5%
Min Revenue beat(4)-16.69%
Max Revenue beat(4)6.54%
Revenue beat(8)6
Avg Revenue beat(8)-0.8%
Revenue beat(12)8
Avg Revenue beat(12)-0.12%
Revenue beat(16)9
Avg Revenue beat(16)-2.55%
PT rev (1m)4.97%
PT rev (3m)13.02%
EPS NQ rev (1m)-5.26%
EPS NQ rev (3m)0%
EPS NY rev (1m)-83.07%
EPS NY rev (3m)-83.07%
Revenue NQ rev (1m)22.15%
Revenue NQ rev (3m)30.41%
Revenue NY rev (1m)-6.63%
Revenue NY rev (3m)-6.63%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11.09
P/S 6.9
P/FCF N/A
P/OCF 63.09
P/B 3.23
P/tB 3.23
EV/EBITDA 45.18
EPS(TTM)-0.21
EYN/A
EPS(NY)0.53
Fwd EY9.02%
FCF(TTM)-0.56
FCFYN/A
OCF(TTM)0.09
OCFY1.59%
SpS0.85
BVpS1.82
TBVpS1.82
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.99%
ROE -13.16%
ROCE 0.35%
ROIC 0.28%
ROICexc 0.3%
ROICexgc 0.3%
OM 1.11%
PM (TTM) N/A
GM 16.47%
FCFM N/A
ROA(3y)-0.51%
ROA(5y)0.76%
ROE(3y)-0.98%
ROE(5y)0.74%
ROIC(3y)2.76%
ROIC(5y)N/A
ROICexc(3y)3.56%
ROICexc(5y)N/A
ROICexgc(3y)3.56%
ROICexgc(5y)N/A
ROCE(3y)3.5%
ROCE(5y)N/A
ROICexcg growth 3Y-31.89%
ROICexcg growth 5YN/A
ROICexc growth 3Y-31.88%
ROICexc growth 5YN/A
OM growth 3Y-2.72%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5YN/A
F-Score3
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA 3.01
Cap/Depr 503.82%
Cap/Sales 76.86%
Interest Coverage 0.27
Cash Conversion 66.81%
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.65
Altman-Z 1.86
F-Score3
WACC9.36%
ROIC/WACC0.03
Cap/Depr(3y)485.81%
Cap/Depr(5y)353.29%
Cap/Sales(3y)66.44%
Cap/Sales(5y)50.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-600%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
EPS Next Y141.03%
EPS Next 2Y193.95%
EPS Next 3Y97.31%
EPS Next 5Y55.42%
Revenue 1Y (TTM)11.64%
Revenue growth 3Y9.6%
Revenue growth 5Y12.33%
Sales Q2Q%46.41%
Revenue Next Year81.85%
Revenue Next 2Y74.22%
Revenue Next 3Y46.65%
Revenue Next 5Y33.18%
EBIT growth 1Y100.07%
EBIT growth 3Y6.61%
EBIT growth 5YN/A
EBIT Next Year214.33%
EBIT Next 3Y84.98%
EBIT Next 5Y52.74%
FCF growth 1Y-134.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.85%
OCF growth 3Y-6.61%
OCF growth 5YN/A